Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
life sciences
national blog main
national top stories
new york blog main
startups
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
medicines
3
×
bio
covid
ipo
roundup
years
acquisitions
activity
adding
ago
aiming
announced
approvals
balance
biogen
build
ceo
clamped
collabs
daniel
deal
decibel
delays
developing
drugs
economic
emerged
fast
fda
focus
forms
gilead
gilead’s
hearing
help
including
introduce
isn’t
loss
lot
Language
unset
3
×
Current search:
unset
×
startups
×
medicines
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus